North America Hydrocephalus Shunts Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Age Group (Pediatric and Adults), Type (Ventriculo-Peritoneal, Ventriculo-Atrial, Ventriculo-Pleural, and Lumbo-Peritoneal), Product (Hydrocephalus Val

North America Hydrocephalus Shunts Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Age Group (Pediatric and Adults), Type (Ventriculo-Peritoneal, Ventriculo-Atrial, Ventriculo-Pleural, and Lumbo-Peritoneal), Product (Hydrocephalus Valves, Hydrocephalus Catheters, Neuronavigation Systems, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)

The North America hydrocephalus shunts market is expected to grow from US$ 122.61 million in 2022 to US$ 150.64 million by 2028. It is estimated to record a CAGR of 3.5% from 2022 to 2028.

Increasing Prevalence of Hydrocephalus Bolsters North America Hydrocephalus Shunts Market Growth

Cerebrospinal fluid (CSF) in the brain and spinal cord protects the central nervous system from injuries and infections. The accumulation of excess CSF in brain cavities adds to intracranial pressure, thereby leading to hydrocephalus. The condition may further lead to macrocephaly and cognitive dysfunctions. Hydrocephalus is more prevalent in children and infants than in the adult population. The disease is also prevalent in people aged 60 and above. According to the Hydrocephalus Association, the disease affects over 1 million Americans. Additionally, the incidence rate of hydrocephalus in the US is 1 in every 770 babies. The treatment approach of hydrocephalus highly focuses on managing CSF through medical devices named shunts. The shunt systems remove excess cerebrospinal fluid from the brain and divert it to other body parts, wherein it is absorbed as a part of the circulatory process. Thus, the high incidence of hydrocephalus drives the demand for hydrocephalus shunts, thereby boosting the North America hydrocephalus shunts market growth.

Market Overview

The North America hydrocephalus shunts market has been segmented into the US, Canada, and Mexico. The US is the key contributor to the market in this region. The market growth in this region is attributed to the rise in health concerns with increasing neurological disease incidence and the availability of a well-developed healthcare structure. According to the Hydrocephalus Organization, hydrocephalus is a neurological disorder that affects 1 out of 770 new-born and 1 out of 100 senior citizens in America. Furthermore, high investments by key medical companies in the R&D of neurosurgical devices to lower the socioeconomic burden of hydrocephalus boost the market growth in North America.

North America Hydrocephalus Shunts Market Revenue and Forecast to 2028 (US$ Million)

North America Hydrocephalus Shunts Market Segmentation

The North America hydrocephalus shunts market is segmented on the basis of age group, type, product, end user and country.

Based on age group, the North America hydrocephalus shunts market is bifurcated into pediatric and adults. The pediatric segment is expected to hold a larger market share in 2022.

In terms of type, the North America hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritonea. The ventriculo-peritoneal segment would hold the largest market share in 2022.

The North America hydrocephalus shunts market, by product, is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves segment is expected to dominate the market in 2022.

Based on end user, the North America hydrocephalus shunts market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment is likely to dominate the market in 2022.

In terms of country, the North America hydrocephalus shunts market is segmented into US, Canada, and Mexico. The US is expected to dominate the market in 2022.

B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG); Sophysa; HpBio Próteses, inc. ; Integra LifeSciences Holdings Corporation; KANEKA MEDIX CORP.; Medtronic; Natus Medical Incorporated; and Spiegelberg GmbH & Co. KG. are the leading companies operating in the North America hydrocephalus shunts market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America hydrocephalus shunts market
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America hydrocephalus shunts market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution